Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $839.71 billion, total revenue of $173.15 billion and a weighted average PE ratio of 46.77.
Market Cap
839.71B
Revenue
173.15B
Profits
17.95B
PE Ratio
46.77
Profit Margin
10.37%
Dividend Yield
0.20%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 226.94B | -0.75% | 1,229,017 | 46.34B |
| 2 | DHR | Danaher Corporation | 145.98B | -1.60% | 2,898,106 | 25.11B |
| 3 | NTRA | Natera, Inc. | 47.31B | 0.16% | 968,016 | 2.71B |
| 4 | IQV | IQVIA Holdings Inc. | 44.07B | -1.42% | 1,197,936 | 16.98B |
| 5 | A | Agilent Technologies, Inc. | 42.53B | 0.59% | 1,825,227 | 7.37B |
| 6 | IDXX | IDEXX Laboratories, Inc. | 42.18B | 1.15% | 407,862 | 4.55B |
| 7 | WAT | Waters Corporation | 40.22B | -1.01% | 352,136 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 32.95B | -1.55% | 1,748,099 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.95B | -0.81% | 103,029 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.51B | -1.39% | 438,649 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.17B | -0.94% | 798,699 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 21.66B | 0.23% | 2,402,367 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.50B | -0.35% | 146,428 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.53B | -0.31% | 1,175,212 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 13.77B | -1.65% | 738,886 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.72B | 0.78% | 796,393 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.99B | -0.89% | 1,922,420 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 7.82B | -3.10% | 901,802 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 5.80B | -1.22% | 497,537 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.39B | -0.68% | 1,089,522 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.69B | -0.11% | 976,419 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.87B | -1.18% | 1,404,176 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.59B | -0.35% | 434,817 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.42B | -4.79% | 992,180 | 561.90M |
| 25 | CDNA | CareDx, Inc. | 2.63B | 2.05% | 1,307,394 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.56B | -1.60% | 304,411 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.23B | -0.46% | 997,009 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.84B | 2.20% | 2,522,867 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.75B | -3.49% | 621,948 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.22B | 1.86% | 2,350,122 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.01B | 0.80% | 187,714 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 542.88M | 0.41% | 224,998 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 305.12M | -1.24% | 806,164 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 276.23M | -1.13% | 58,744 | 102.94M |
| 35 | XGN | Exagen Inc. | 183.63M | 0.53% | 138,170 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 135.15M | 0.24% | 183,521 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 133.67M | 4.61% | 1,181,483 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 126.45M | 11.22% | 97,560 | 74.58M |
| 39 | MDXH | MDxHealth SA | 71.41M | 3.06% | 271,597 | 114.02M |
| 40 | PRPO | Precipio, Inc. | 49.05M | 4.90% | 114,537 | 27.20M |
| 41 | ADVB | Advanced Biomed Inc. | 15.42M | -0.69% | 66,457 | - |
| 42 | NDRA | ENDRA Life Sciences Inc. | 9.07M | 6.51% | 20,482 | - |
| 43 | XWEL | XWELL, Inc. | 8.38M | 0.57% | 16,438 | 28.28M |
| 44 | BIAF | bioAffinity Technologies, Inc. | 8.24M | 19.48% | 20,085,150 | 5.90M |
| 45 | ISPC | iSpecimen Inc. | 3.88M | - | 6,163,315 | 466.30K |